PD L1 News and Research

RSS
New model uses blood tests to predict lung cancer prognosis

New model uses blood tests to predict lung cancer prognosis

Tumor genetics and immune profiling guide lung cancer immunotherapy

Tumor genetics and immune profiling guide lung cancer immunotherapy

Chronic stress promotes oral cancer through a brain–immune pathway

Chronic stress promotes oral cancer through a brain–immune pathway

New treatment approach could help people with muscle-invasive bladder cancer live longer

New treatment approach could help people with muscle-invasive bladder cancer live longer

New review outlines role of extracellular vesicles in cancer and aging

New review outlines role of extracellular vesicles in cancer and aging

Dual-targeting antibody successfully tackles multiple tumor types in mice

Dual-targeting antibody successfully tackles multiple tumor types in mice

New mathematical model tracks how tumor environment impacts cancer therapies

New mathematical model tracks how tumor environment impacts cancer therapies

AI tools help predict immunotherapy outcomes in lung cancer patients

AI tools help predict immunotherapy outcomes in lung cancer patients

Research identifies novel prognostic biomarkers for class II and III BRAF-altered cancers

Research identifies novel prognostic biomarkers for class II and III BRAF-altered cancers

Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC

Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC

Ivonescimab shows significant survival benefit for patients with PD-L1-positive NSCLC

Ivonescimab shows significant survival benefit for patients with PD-L1-positive NSCLC

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

Targeted nanoparticles strengthen anti-cancer immune responses in tumors

Targeted nanoparticles strengthen anti-cancer immune responses in tumors

New treatment approach preserves organs, improves survival in head and neck cancer patients

New treatment approach preserves organs, improves survival in head and neck cancer patients

Study shows how the microbiome shapes lung cancer immunotherapy outcomes

Study shows how the microbiome shapes lung cancer immunotherapy outcomes

Microscopic peptide droplets reduce colorectal tumor growth in mice

Microscopic peptide droplets reduce colorectal tumor growth in mice

Post-surgery immunotherapy may not benefit specific lung cancer patients

Post-surgery immunotherapy may not benefit specific lung cancer patients

Immunotherapy shows potential for treating rising gynecological tumors

Immunotherapy shows potential for treating rising gynecological tumors

Study identifies KRAS G12C as a precision-medicine target in genitourinary cancers

Study identifies KRAS G12C as a precision-medicine target in genitourinary cancers

Disrupted brain-immune signaling may help drive neurodegeneration

Disrupted brain-immune signaling may help drive neurodegeneration

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.